WILATE 500 Israeli - Kiingereza - Ministry of Health

wilate 500

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).

ALEVIATE human coagulation factor VIII 500IU / von Willebrand Factor 1200IU powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

aleviate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial

csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.

FEIBA-NF factor eight inhibitor bypassing fraction 1000U powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

feiba-nf factor eight inhibitor bypassing fraction 1000u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 1000 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

FEIBA-NF factor eight inhibitor bypassing fraction 500U powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

feiba-nf factor eight inhibitor bypassing fraction 500u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 500 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

CSL Hong Kong Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU complex, Powder for injection (50 IU/mL FVIII) Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl hong kong aleviate human coagulation factor viii 500iu/von willebrand factor 1000iu complex, powder for injection (50 iu/ml fviii)

csl behring australia pty ltd - von willebrand factor, quantity: 1000 iu; factor viii, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor fviii deficiency due to haemophilia a.

Dried Factor VIII Fraction type 8Y 250unit powder and solvent for solution for injection vials Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

dried factor viii fraction type 8y 250unit powder and solvent for solution for injection vials

bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit

Haemate P 1200 IU vWF/500 IU FVIII 1 200 IU - 500 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 1200 iu vwf/500 iu fviii 1 200 iu - 500 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human factor von willebrand 1200 iu; human coagulation factor viii 500 iu - powder and solvent for solution for injection/infusion - 1200 iu - 500 iu - human coagulation factor viii 500 iu; factor von willebrand 1200 iu - von willebrand factor and coagulation factor viii in combination

Haemate P 2400 IU vWF/1000 IU FVIII 2 400 IU - 1 000 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 2400 iu vwf/1000 iu fviii 2 400 iu - 1 000 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human factor von willebrand 2400 iu; human coagulation factor viii 1000 iu - powder and solvent for solution for injection/infusion - 2400 iu - 1000 iu - human coagulation factor viii 1000 iu; factor von willebrand 2400 iu - von willebrand factor and coagulation factor viii in combination

Haemate P 600 IU vWF/250 IU FVIII 600 IU - 250 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 600 iu vwf/250 iu fviii 600 iu - 250 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human coagulation factor viii 250 iu; human factor von willebrand 600 iu - powder and solvent for solution for injection/infusion - 600 iu - 250 iu - human coagulation factor viii 250 iu; factor von willebrand 600 iu - von willebrand factor and coagulation factor viii in combination

KOVALTRY 1000 IU Israeli - Kiingereza - Ministry of Health

kovaltry 1000 iu

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 1000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.